These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1737385

  • 1. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
    De Coster R, Van Ginckel RF, Callens MJ, Goeminne NK, Janssens BL.
    Cancer Res; 1992 Mar 01; 52(5):1240-4. PubMed ID: 1737385
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T, Urabe M, Tamura T, Kitawaki J, Honjo H, Okada H.
    Anticancer Res; 1991 Mar 01; 11(6):1999-2002. PubMed ID: 1776832
    [Abstract] [Full Text] [Related]

  • 3. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N, Koibuchi Y, Iino Y, Morishita Y.
    Int J Oncol; 1999 Feb 01; 14(2):259-63. PubMed ID: 9917500
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y, Karakida T, Sugamata N, Andoh T, Takei H, Takahashi M, Yaguchi S, Matsuno T, Takehara M, Sakato M, Kawashima S, Morishita Y.
    Anticancer Res; 1998 Feb 01; 18(1A):171-6. PubMed ID: 9568073
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
    Van Ginckel R, Janssens B, Callens M, Goeminne N, Wouters L, De Coster R.
    Cancer Chemother Pharmacol; 1996 Feb 01; 38(1):21-8. PubMed ID: 8603447
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG.
    Cancer Treat Rep; 1987 Nov 01; 71(11):1021-7. PubMed ID: 3119199
    [Abstract] [Full Text] [Related]

  • 7. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA, Asselin J, Caron MG, Raynaud JP, Labrie F.
    Cancer Res; 1977 Jan 01; 37(1):76-81. PubMed ID: 187338
    [Abstract] [Full Text] [Related]

  • 8. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Boccuzzi G, Aragno M, Brignardello E, Tamagno E, Conti G, Di Monaco M, Racca S, Danni O, Di Carlo F.
    Anticancer Res; 1992 Jan 01; 12(5):1479-83. PubMed ID: 1444210
    [Abstract] [Full Text] [Related]

  • 9. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
    Schieweck K, Bhatnagar AS, Matter A.
    Cancer Res; 1988 Feb 15; 48(4):834-8. PubMed ID: 2962734
    [Abstract] [Full Text] [Related]

  • 10. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY, Garrett WM, Brodie AM.
    Cancer Res; 1985 Jun 15; 45(6):2425-8. PubMed ID: 3921242
    [Abstract] [Full Text] [Related]

  • 11. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M, Yano S, Hasegawa Y, Nakao K.
    Arzneimittelforschung; 1994 Jun 15; 44(6):774-8. PubMed ID: 8053980
    [Abstract] [Full Text] [Related]

  • 12. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM, Bambara RA, Zain S, Hilf R.
    Cancer Res; 1989 Mar 01; 49(5):1165-70. PubMed ID: 2492902
    [Abstract] [Full Text] [Related]

  • 13. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Lubet RA, Steele VE, DeCoster R, Bowden C, You M, Juliana MM, Eto I, Kelloff GJ, Grubbs CJ.
    Carcinogenesis; 1998 Aug 01; 19(8):1345-51. PubMed ID: 9744527
    [Abstract] [Full Text] [Related]

  • 14. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW, Ip C, Ip MM.
    Cancer Res; 1986 Feb 01; 46(2):763-9. PubMed ID: 3079669
    [Abstract] [Full Text] [Related]

  • 15. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW, Li PK.
    Cancer Res; 1988 Dec 01; 48(23):6808-10. PubMed ID: 3141048
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y, Sugamata N, Owada S, Tago T, Sato H, Yokoe T, Maemura M, Morishita Y, Horiuchi R.
    Jpn J Clin Oncol; 1991 Jun 01; 21(3):153-9. PubMed ID: 1834875
    [Abstract] [Full Text] [Related]

  • 17. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW, Aylsworth CF, Van Vugt DA, Meites J.
    Cancer Res; 1983 Nov 01; 43(11):5342-6. PubMed ID: 6413057
    [Abstract] [Full Text] [Related]

  • 18. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    Néri C, Blangy D, Schatz B, Drieu K, Berebbi M, Martin PM.
    Cancer Res; 1990 Sep 15; 50(18):5892-7. PubMed ID: 2168284
    [Abstract] [Full Text] [Related]

  • 19. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.
    Clin Cancer Res; 2006 Jul 01; 12(13):4062-71. PubMed ID: 16818706
    [Abstract] [Full Text] [Related]

  • 20. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH.
    Cancer Res; 1982 Aug 01; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.